Same once-daily injection, same compounding pharmacy, broader anti-inflammatory coverage where the surgical field calls for it
According to the American Society of Anesthesiologists consensus guidelines, if the patient has reported gastrointestinal side effects of nausea or vomiting due to a GLP-1 receptor agonist, they must be considered at increased risk for complications requiring full-stomach precautions for anesthesia
At 10 mg/ml, twenty units would be 2 mg, a potentially dangerous amount for someone in early dose escalation
Patients can move forward with confidence, knowing their treatment is based on evidence and individual health needs
Their ability to solve challenges related to sequence length, solubility, and modifications allows us to meet even the most demanding synthesis needs